Home Diagnostics to Present at the 9th Annual CJS Securities "New Ideas for the New Year" Investor Conference

Business Wire, Dec 23, 2008

FORT LAUDERDALE, Fla. -- Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that J. Richard Damron, Jr., President and Chief Executive Officer, and Ronald Rubin, Chief Financial Officer, of Home Diagnostics are scheduled to present at the 9th Annual CJS Securities "New Ideas for the New Year" Investor Conference on Wednesday, January 7, 2009 in New York City.

About Home Diagnostics, Inc.

Based in Fort Lauderdale, Florida, Home Diagnostics, Inc. (NASDAQ:HDIX) is a leading developer, manufacturer and marketer of diabetes management solutions. Home Diagnostics, Inc. offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics, Inc. product line includes TRUE2go[TM], TRUEresult[TM], TRUEtest[TM], TRUEtrack[R], Sidekick[R], TRUEread[TM] and Prestige IQ[R] blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand supplier of blood glucose monitoring supplies for leading pharmacies including CVS, Rite Aid and Walgreens as well as national distributors such as AmerisourceBergen, Cardinal Health and McKesson. For more information please visit www.homediagnostics.com.

TRUE2go, TRUEresult, TRUEtest, TRUEtrack, Sidekick, TRUEread and Prestige IQ are trademarks of Home Diagnostics, Inc. All other trademarks are property of their respective owners.

[HDIX-F]